KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Feb 29, 2016 $26.19 $26.78 $25.30 $25.34 564 300
Feb 26, 2016 $25.10 $26.29 $24.71 $25.32 394 400
Feb 25, 2016 $26.14 $26.24 $23.74 $24.18 476 200
Feb 24, 2016 $25.77 $28.00 $24.54 $26.40 255 300
Feb 23, 2016 $26.62 $27.69 $25.99 $26.07 292 300
Feb 22, 2016 $27.47 $28.27 $26.50 $26.73 381 200
Feb 19, 2016 $26.17 $27.51 $25.65 $27.20 225 900
Feb 18, 2016 $28.97 $29.96 $26.13 $26.27 363 400
Feb 17, 2016 $27.16 $29.25 $27.09 $28.93 484 800
Feb 16, 2016 $25.80 $26.98 $25.10 $26.91 303 800
Feb 12, 2016 $25.06 $27.30 $23.80 $25.41 223 500
Feb 11, 2016 $24.98 $25.49 $24.02 $24.83 281 600
Feb 10, 2016 $24.83 $26.82 $24.37 $25.67 438 300
Feb 09, 2016 $24.38 $25.77 $24.16 $24.63 207 300
Feb 08, 2016 $26.23 $26.70 $23.40 $24.83 520 400
Feb 05, 2016 $27.80 $28.27 $26.48 $26.59 410 000
Feb 04, 2016 $28.11 $30.11 $27.51 $28.00 363 700
Feb 03, 2016 $29.28 $30.19 $26.52 $28.45 829 300
Feb 02, 2016 $30.24 $30.24 $27.67 $28.82 713 000
Feb 01, 2016 $30.84 $33.89 $29.11 $30.77 571 200
Jan 29, 2016 $30.71 $34.20 $30.21 $30.70 834 900
Jan 28, 2016 $32.28 $34.99 $29.52 $30.71 586 500
Jan 27, 2016 $33.72 $34.83 $32.08 $32.25 451 700
Jan 26, 2016 $36.17 $36.17 $32.23 $33.59 665 400
Jan 25, 2016 $35.41 $37.00 $34.78 $35.64 479 300
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT